Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Laba Operasional
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 13.74B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Laba Operasional
Perubahan
Tanggal
Agilent
USD 399M
46M
2026-03
Align Technology
USD 178.05M
46.66M
2026-03
Bio Techne
USD 75.49M
21.03M
2026-03
Bio-Rad Laboratories
USD 53.9M
10M
2025-12
Bruker
USD 10.2M
66.1M
2026-03
Celltrion
KRW 13.72B
287.31B
2025-12
Charles River Laboratories
USD 119.9M
44.08M
2026-03
Cspc Pharmaceutical
CNY 206.26M
1.02B
2025-12
Danaher
USD 1.34B
158M
2026-03
Dentsply International
USD 32M
506M
2026-03
Deva Holding AS
TRY 964.87M
240.32M
2023-09
Dianthus Therapeutics
USD -69.54M
29.25M
2025-12
Divis Laboratories Ltd
INR 8.14B
420M
2026-03
Edwards Lifesciences
USD 514.7M
144.4M
2026-03
Illumina
USD 239M
17M
2026-03
Intuitive Surgical
USD 859.7M
5.6M
2026-03
IQVIA Holdings
USD 565M
2.11B
2026-03
Kangmei Pharma
CNY -10.94M
15.75M
2026-03
Knight Therapeutics
CAD 6.21M
3.27M
2025-12
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Laboratory Of America
USD 410.1M
28.1M
2026-03
Malin Corporation
EUR -1.1M
400K
2024-12
Medical Developments International
AUD -36K
444K
2025-12
Mesa Laboratories
USD 5.78M
2.27M
2024-12
Mettler Toledo International
USD 233.93M
118M
2026-03
Myriad Genetics
USD -3M
20.3M
2025-12
Neuren Pharmaceuticals
AUD 17.01M
11.56M
2025-12
OraSure Technologies
USD -13.59M
2.13M
2025-12
Organigram Holdings
CAD -20.13M
7.92M
2025-12
Ovoca Bio
EUR -1.16M
4.48M
2025-06
Pacific Biosciences Of California
USD -53.19M
35.08M
2025-12
Pharma Mar
EUR 622K
42.99M
2026-03
Qiagen NV
USD 121.88M
15.41M
2025-12
Quest Diagnostics
USD 399M
13M
2026-03
Quidel
USD -31.8M
5.5M
2026-03
Repligen
USD 19.98M
13K
2026-03
Revvity
USD 82.77M
63.06M
2026-03
Sartorius
EUR 160.7M
9.5M
2026-03
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
Thermo Fisher Scientific
USD 1.91B
389M
2026-03
Tilray
USD -20.01M
9.34M
2025-09
Waters
USD 148M
122.52M
2026-03
Zealand Pharma A/S
-707.05M
245.73M
2025-12
Zz Pientze Pharmaceu
CNY 837.81M
336.48M
2026-03
×